Craft

Daewon Pharmaceutical

Stock Price

₩14.5 K

2024-10-29

Market Capitalization

₩305.2 B

2024-10-29

Revenue

₩527 B

FY, 2023

Daewon Pharmaceutical Summary

Company Summary

Overview
Daewon Pharmaceutical (대원제약) is a company that specializes in the production and sale of medicines and medical supplies. It provides a range of products dedicated to the circulatory, respiratory, psychiatric, and nervous systems. The company is engaged in the production of antibiotics, analgesics, vitamins, health foods, and more.
Type
Public
Status
Active
Founded
1958
HQ
KR | view all locations
Website
https://www.daewonpharm.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    386 Cheonho-daero, Yongdap-dong, Seongdong-gu

Daewon Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2024)
₩156.8B
Gross profit (Q3, 2024)
₩78.7B
Net income (Q3, 2024)
₩5.6B
Cash (Q3, 2024)
₩15.7B
EBIT (Q3, 2024)
₩10.7B
Enterprise value
$479.3B

Footer menu